“This new facility further strengthens our balance sheet and enhances our ability to execute our strategic plan,” said
“This capital commitment from Hercules aims to help
Key Credit Facility Terms:
$35 million funded at loan closing, with up to an additional$30 million potentially available (subject to certain conditions as described in the credit agreements)- 54-month maturity, with interest-only period of 30 months, which can be extended to 36 months subject to achievement of certain performance milestones
The credit facility is secured by substantially all of the Company’s assets. Additional details regarding the Company’s debt refinancing will be filed with the
About
For more information, visit www.sightsciences.com.
OMNI, SION, and TearCare are registered trademarks of
© 2024
Forward-Looking Statements
This press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements are subject to considerable risks and uncertainties. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Any statements made in this press release that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements herein include, without limitation, statements concerning the terms of the new secured credit facility with Hercules including the amount of available borrowings, and the Company’s ability to expand its financial flexibility through the utilization of the credit facility with Hercules. These statements often include words such as “anticipate,” “expect,” “suggests,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast” and other similar expressions. We base these forward-looking statements on our current expectations, plans and assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate under the circumstances at such time. Although management believes these forward-looking statements are based upon reasonable assumptions at the time they are made, management cannot guarantee their accuracy or completeness. Forward-looking statements are subject to and involve risks, uncertainties and assumptions that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance, or achievements predicted, assumed or implied by such forward-looking statements. Some of the risks and uncertainties that may cause actual results to materially differ from those expressed or implied by these forward-looking statements are discussed under the caption “Risk Factors” in the Company’s filings with the
Media contact:
pr@SightSciences.com
Investor contact:
415.937.5406
Investor.Relations@Sightsciences.com
Source:
2024 GlobeNewswire, Inc., source